LUCY Stock Price, Innovative Eyewear, Inc. Quote, Chart

Market Summary

USD0.200.00

Delayedas of 01 May 2024, 11:13 am

0.00%

LUCY Stock Price

View Fullscreen

LUCY RSI Chart

LUCY Valuation

Market Cap

2.6M

Price/Earnings (Trailing)

-0.39

Price/Sales (Trailing)

2.24

Price/Free Cashflow

-0.44

LUCY Price/Sales (Trailing)

LUCY Profitability

Operating Margin

-10.35%

Return on Equity

-119.87%

Return on Assets

-107.15%

Free Cashflow Yield

-225.95%

LUCY Fundamentals

LUCY Revenue

Revenue (TTM)

1.2M

Rev. Growth (Yr)

818.1%

Rev. Growth (Qtr)

177.52%

LUCY Earnings

Earnings (TTM)

-6.7M

Earnings Growth (Yr)

-27.52%

Earnings Growth (Qtr)

-54.32%

Breaking Down LUCY Revenue

52 Week Range

0.21

(Low)(High)

Last 7 days

-20%

Last 30 days

-25.9%

Last 90 days

-53.5%

How does LUCY drawdown profile look like?

LUCY Financial Health

Current Ratio

8.99

LUCY Investor Care

Shares Dilution (1Y)

67.63%

Diluted EPS (TTM)

-0.63

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	568.7K	533.9K	603.8K	1.2M
2022	682.9K	675.2K	667.5K	659.8K
2021	0	0	0	690.7K

Get all data in R, Python etc through our Historical Stock Data APIs

Which funds bought or sold LUCY recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Mar 11, 2024	VANGUARD GROUP INC	unchanged	-	-6,650	19,928	-%
Feb 26, 2024	Privium Fund Management B.V.	unchanged	-	-9,259	4,598	-%
Feb 26, 2024	Virtu Financial LLC	added	6.24	-2,000	8,000	-%
Feb 14, 2024	BANK OF AMERICA CORP /DE/	sold off	-100	-13.00	-	-%
Feb 14, 2024	BANK OF AMERICA CORP /DE/	new	-	105	105	-%
Feb 14, 2024	CLEAR STREET LLC	added	0.06	-18,000	9,000	-%
Feb 14, 2024	SABBY MANAGEMENT, LLC	sold off	-100	-13,454,000	-	-%
Feb 14, 2024	Hudson Bay Capital Management LP	reduced	-50.00	-28,267	6,103	-%
Feb 14, 2024	CITADEL ADVISORS LLC	sold off	-100	-20,337	-	-%
Feb 14, 2024	CITADEL ADVISORS LLC	reduced	-1.48	-3,626	1,952	-%

Are Funds Buying or Selling LUCY?

Are funds buying LUCY calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own LUCY

No. of Funds

Recent SEC filings of Innovative Eyewear, Inc.

View All Filings

Date Filed	Form Type	Document
Apr 29, 2024	8-K	Current Report
Apr 16, 2024	8-K	Current Report
Apr 15, 2024	424B5	Prospectus Filed
Mar 29, 2024	EFFECT	EFFECT
Mar 27, 2024	CORRESP	CORRESP
Mar 26, 2024	S-3/A	S-3/A
Mar 25, 2024	10-K	Annual Report
Feb 07, 2024	S-3	S-3

Peers (Alternatives to Innovative Eyewear, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	183.9B	40.1B	-6.77%	-4.63%	32.13	4.58	-8.12%	-17.45%
BDX	67.8B	19.5B	-5.19%	-11.58%	53.96	3.48	4.02%	-22.04%
ALGN	21.2B	3.9B	-13.89%	-11.01%	47.65	5.49	3.42%	23.09%
BAX	20.5B	14.8B	-5.55%	-14.80%	7.72	1.38	2.12%	209.17%
MID-CAP
ATR	9.6B	3.5B	0.34%	19.07%	30.58	2.7	6.16%	35.06%
HSIC	8.9B	12.3B	-8.26%	-15.92%	21.4	0.72	-2.44%	-22.68%
BIO	7.9B	2.7B	-22.01%	-40.57%	-12.36	2.95	-4.68%	82.43%
XRAY	6.2B	4.0B	-9.58%	-29.21%	-46.27	1.57	1.10%	85.84%
AXNX	3.4B	387.1M	-3.48%	13.50%	-213.32	8.77	30.82%	65.60%
PDCO	2.3B	6.6B	-7.88%	-6.70%	11.79	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-14.42%	-16.17%	-1.93	0.41	7.73%	-1066.14%
ANIK	383.9M	166.7M	1.93%	-0.42%	-4.64	2.3	6.67%	-456.34%
ANGO	231.9M	324.0M	-1.36%	-32.67%	-1.21	0.72	-3.19%	-337.41%
APYX	49.5M	52.3M	5.15%	-61.35%	-2.65	0.95	17.61%	19.28%
AEMD	3.6M	3.7M	-17.86%	283.33%	-0.3	0.96	5.77%	8.23%

Innovative Eyewear, Inc. News

Latest updates

Innovative Eyewear, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)											(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2
Revenue	177.5%	616	222	170	145	67.00	152	205	236	204	171	127
Cost Of Revenue	462.4%	796	142	200	135	264	129	161	162	-	130	94.00
Gross Profit	-324.2%	-180	80.00	-29.82	10.00	-196	23.00	43.00	74.00	-	41.00	33.00
Operating Expenses	38.1%	2,315	1,677	1,304	1,439	1,680	1,389	1,190	1,263	-	1,132	550
S&GA Expenses	115.4%	1,150	534	104	259	513	569	392	585	-	513	271
R&D Expenses	-37.3%	121	193	197	151	132	305	53.00	36.00	-	9.00	19.00
Interest Expenses	-	-	-	1.00	2.00	4.00	38.00	45.00	18.00	-	10.00	15.00
Net Income	-54.3%	-2,393	-1,551	-1,287	-1,430	-1,877	-1,404	-1,193	-1,206	-1,385	-1,100	-536
Net Income Margin	43.2%	-5.78*	-10.18*	-11.24*	-10.39*	-8.61*	-7.78*	-7.24*	-6.19*	-4.70*	-	-
Free Cashflow	22.4%	-1,109	-1,429	-1,850	-1,455	-1,148	-1,020	-513	-662	-	-	-

Balance Sheet

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Balance Sheet								(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2021Q4
Assets	-23.4%	6,219	8,116	9,340	5,113	4,690	6,418	1,101	824
Current Assets	-25.1%	5,617	7,501	8,770	4,542	4,241	6,102	835	644
Cash Equivalents	9.8%	4,287	3,904	5,356	3,450	3,591	4,976	35.00	80.00
Inventory	-31.3%	533	776	660	743	95.00	423	325	276
Net PPE	-25.6%	133	178	125	138	120	98.00	53.00	20.00
Liabilities	39.3%	660	474	389	563	665	851	2,453	617
Current Liabilities	44.8%	624	431	331	505	600	851	2,453	617
LT Debt, Current	-	-	-	-	-	61.00	166	1,938	289
Shareholder's Equity	-27.3%	5,559	7,642	8,951	4,550	4,024	5,567	-	208
Retained Earnings	-16.4%	-16,969	-14,575	-13,024	-11,736	-10,305	-8,428	-7,024	-4,624
Additional Paid-In Capital	1.4%	22,528	22,218	21,976	16,287	14,330	14,000	5,677	4,843
Shares Outstanding	0%	12,917	12,917	12,917	7,716	7,307	6,673	6,060	6,060
Float	-	-	-	6,917	-	-	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)											(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2
Cashflow From Operations	16.4%	-1,135	-1,359	-1,843	-1,427	-1,117	-970	-505	-630	-	-	-
Share Based Compensation	28.1%	310	242	-40.18	424	335	305	417	417	-	-	-
Cashflow From Investing	2251.6%	2,010	-93.42	-1,978	-136	-64.52	-57.67	-15.09	-82.66	-	-	-
Cashflow From Financing	-Infinity%	-490	-	5,729	1,423	-203	5,970	513	676	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

LUCY Income Statement

2023-12-31

STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
STATEMENTS OF OPERATIONS - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenues, net	$ 1,152,479	$ 659,788
Less: Cost of Goods Sold	(1,271,808)	(716,077)
Gross Deficit	(119,329)	(56,289)
Operating Expenses:
General and administrative	(3,886,960)	(2,796,669)
Sales and marketing	(2,047,069)	(2,059,012)
Research and development	(662,184)	(524,692)
Related party management fee	(140,000)	(140,000)
Total Operating Expenses	(6,736,213)	(5,520,373)
Other Income (Expense)	195,150
Interest Expense	(3,036)	(105,171)
Total Other Income (Expense), net	192,114	(105,171)
Net Loss	$ (6,663,428)	$ (5,681,833)
Weighted average number of shares outstanding	10,515,995	6,528,959
Loss per share, basic	$ (0.63)	$ (0.87)
Loss per share, diluted	$ (0.63)	$ (0.87)

LUCY Balance Sheet

2023-12-31

BALANCE SHEETS - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Current Assets
Cash and cash equivalents	$ 4,287,447	$ 3,591,109
Accounts receivable, net of allowances of $25,772 and $92,646, respectively	93,211	110,258
Prepaid expenses	313,648	210,673
Inventory prepayment	323,520	197,750
Inventory	533,239	94,701
Due from Tekcapital and Affiliates	6,256
Other current assets	59,447	36,240
Total Current Assets	5,616,768	4,240,731
Non-Current Assets
Patent costs, net	286,429	137,557
Capitalized software costs	110,073	110,073
Property and equipment, net	132,848	119,744
Other non-current assets	72,644	81,779
TOTAL ASSETS	6,218,762	4,689,884
Current Liabilities
Accounts payable and accrued expenses	581,986	275,660
Deferred revenue	42,500	30,000
Due to Tekcapital and Affiliates		232,989
Related party convertible debt		61,356
Total Current Liabilities	624,486	600,005
Non-Current Liabilities
Deferred revenue	35,450	65,450
TOTAL LIABILITIES	659,936	665,455
Commitments and contingencies (Note 7)
Stockholders’ Equity
Common stock (par value $0.00001, 50,000,000 shares authorized, and 12,917,239 and 7,307,157 shares issued and outstanding as of December 31, 2023 and 2022, respectively)	129	73
Additional paid-in capital	22,528,112	14,330,343
Accumulated deficit	(16,969,415)	(10,305,987)
TOTAL STOCKHOLDERS’ EQUITY	5,558,826	4,024,429
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 6,218,762	$ 4,689,884

About Innovative Eyewear, Inc.

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.

CEO	Mr. Harrison Reed Gross
WEBSITE	lucyd.co
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	9

Innovative Eyewear, Inc. Frequently Asked Questions

What is the ticker symbol for Innovative Eyewear, Inc.? What does LUCY stand for in stocks?

LUCY is the stock ticker symbol of Innovative Eyewear, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Innovative Eyewear, Inc. (LUCY)?

As of Tue Apr 30 2024, market cap of Innovative Eyewear, Inc. is 2.59 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of LUCY stock?

You can check LUCY's fair value in chart for subscribers.

What is the fair value of LUCY stock?

You can check LUCY's fair value in chart for subscribers. The fair value of Innovative Eyewear, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Innovative Eyewear, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for LUCY so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Innovative Eyewear, Inc. a good stock to buy?

The fair value guage provides a quick view whether LUCY is over valued or under valued. Whether Innovative Eyewear, Inc. is cheap or expensive depends on the assumptions which impact Innovative Eyewear, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for LUCY.

What is Innovative Eyewear, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 30 2024, LUCY's PE ratio (Price to Earnings) is -0.39 and Price to Sales (PS) ratio is 2.24. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LUCY PE ratio will change depending on the future growth rate expectations of investors.